JG
HUMA icon

Jain Global’s Humacyte HUMA Stock Holding History

Jain Global’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.4K Buy
+114,558
New +$106K ﹤0.01% 1627
2026
Q1 		– Sell
-39,399
Closed -$37.8K – 1405
2025
Q4 		$37.8K Buy
+39,399
New +$55.8K ﹤0.01% 1174

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jain Global's HUMA Position: Q2 2026 in Review

Jain Global opened a new position in Humacyte (HUMA) in Q2 2026: 114,558 shares worth $89.4K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings. This is a return to the name: Jain Global previously reported a position in HUMA as recently as Q4 2025.

Jain Global first reported a position in HUMA in Q4 2025 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Jain Global held 114,558 shares of Humacyte worth $89.4K as of Q2 2026.
  • Humacyte was a new Jain Global position in Q2 2026.
  • Humacyte made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1627 holding.
  • Jain Global first reported a position in Humacyte in Q4 2025 and has held it in 2 quarters since.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.